Astal Laboratories Intrinsic Value
Astal Laboratories intrinsic value. Astal Laboratories (ASTALLTD) median intrinsic value is ₹79.52 from 8 valuation models (range ₹52–₹121), vs current price ₹69.72 — +14.1% upside (Trading Below Median Value), margin of safety 12.3%. Read ASTALLTD dividend track record for the complete payout history and dividend yield track record.
ASTALLTD Valuation Methods Summary — DCF, Graham Number & P/E
Astal Laboratories intrinsic value across 8 models vs current price ₹69.72 — upside/downside and value range per method. Compare with ASTALLTD fair value to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹97.92 | ₹78.34 - ₹117.50 | +40.4% | EPS: ₹8.16, Sector P/E: 12x |
| Book Value Method | asset | ₹79.52 | ₹71.57 - ₹87.47 | +14.1% | Book Value/Share: ₹79.52, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹102.10 | ₹91.89 - ₹112.31 | +46.4% | Revenue/Share: ₹127.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹57.14 | ₹51.43 - ₹62.85 | -18.0% | EBITDA: ₹40.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹52.22 | ₹47.00 - ₹57.44 | -25.1% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹67.24 | ₹60.52 - ₹73.96 | -3.6% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹76.19 | ₹68.57 - ₹83.81 | +9.3% | ROE: 9.6%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹120.83 | ₹108.75 - ₹132.91 | +73.3% | EPS: ₹8.16, BVPS: ₹79.52 |
ASTALLTD Intrinsic Value vs Market Price — All Valuation Models
Astal Laboratories fair value range ₹52–₹121 vs current market price ₹69.72 across 8 valuation models. For current market price and key ratios, visit Astal Laboratories share price today.
ASTALLTD Intrinsic Value Analysis — Undervalued or Overvalued?
Astal Laboratories median intrinsic value ₹79.52, current price ₹69.72 — Trading Below Median Value by 14.1%, margin of safety 12.3%.
What is the intrinsic value of ASTALLTD?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Astal Laboratories (ASTALLTD) is ₹79.52 (median value). With the current market price of ₹69.72, this represents a +14.1% variance from our estimated fair value.
The valuation range spans from ₹52.22 to ₹120.83, indicating ₹52.22 - ₹120.83.
Is ASTALLTD undervalued or overvalued?
Based on our multi-method analysis, Astal Laboratories (ASTALLTD) appears to be trading below median value by approximately 14.1%.
ASTALLTD Financial Health — Key Ratios vs Industry Benchmarks
Astal Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 12.15 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 9.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.03x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ASTALLTD Cash Flow Quality — Operating & Free Cash Flow
Astal Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-18 Cr | ₹-19 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-13 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |